Does Mounjaro Affect the Pill, HRT and the Menopause?

A woman with grey hair in a navy coat and yellow scarf laughs over a coffee at a café window table, a red postbox on the street outside.
In this article
  1. Does Mounjaro affect the pill?
  2. Why does a slower stomach matter for anything you swallow?
  3. What does the four-week pill rule mean in practice?
  4. Does Mounjaro affect HRT?
  5. Emergency contraception and vaginal oestrogen
  6. Does Mounjaro affect your hormones?
  7. Mounjaro at the menopause
  8. What we don't know
  9. Frequently asked questions

Does Mounjaro affect the pill?

It can, in the weeks when the stomach is slowest. In the manufacturer's own study, a single dose of Mounjaro (tirzepatide) taken with a combined pill cut the peak blood level of the pill's oestrogen by 59% and of its two progestogen forms by 55% and 66%, delayed the peaks by 2.5 to 4.5 hours, and cut total exposure by 20% to 23%.1 The product information calls that reduction not clinically relevant in women of normal weight, says there is limited information in women with obesity or overweight, and because reduced effectiveness cannot be excluded advises switching to a non-oral method or adding a barrier method for four weeks after starting and for four weeks after each dose increase.1 The NHS gives the same four-week rule, and the MHRA repeated it in June 2025, naming the implant, coil and condoms as alternatives.2, 3 Oral HRT has no equivalent study and no instruction; the pharmacology is the same, and the evidence is one case report and one hypothesis paper.4, 5

Evidence at a glance

  • The pill: peak levels down 55% to 66% and total exposure down 20% to 23% after a single dose of tirzepatide; barrier or non-oral method for four weeks after starting and after each dose increase.1, 2, 3
  • Why: tirzepatide delays stomach emptying and can change the rate at which oral medicines are absorbed, most of all when treatment starts; the delay diminishes over time.1, 6
  • HRT: no trial. One case report of hot flushes returning on oral oestrogen during a related medicine's dose increases, and one 2026 review calling the interaction with oral progestogens plausible but unproven.4, 5
  • Not affected: patches, gels, sprays, vaginal oestrogen, implants, coils and injections do not pass through the stomach.7

Sources checked on 29 October 2026.

This is one chapter of living well on Mounjaro; Mounjaro side effects in women joins it to periods, hair and iron.

Why does a slower stomach matter for anything you swallow?

Tirzepatide delays how quickly the stomach empties into the small intestine, where most medicines are absorbed. The product information says this can affect the rate of absorption of oral medicines, producing a lower peak and a later one, and that the effect is most pronounced when treatment starts; its pharmacology section adds that the delay diminishes over time, and a four-week study found the same in people with and without diabetes.1, 6 For most medicines that means a later peak and the same total, which is harmless; a 2025 review of GLP-1 medicines and absorption singles out oral contraceptives with tirzepatide as one of two interactions where exposure changed enough to watch.8

What does the four-week pill rule mean in practice?

For four weeks after your first injection and for four weeks after each dose increase, either use condoms, a diaphragm or a cap alongside the pill, or switch to a method that does not go through the stomach: the implant, the injection, the hormonal or copper coil, the patch or the ring.1, 2 The rule covers oral contraceptives generally, so the progestogen-only pill is included. Two things make it worth following to the letter. Weight loss often brings ovulation and regular cycles back to women whose periods had been irregular, so fertility can return while you are on the medicine; and tirzepatide is not used in pregnancy, with the MHRA asking for at least one month between stopping it and trying to conceive.3, 9 Does Mounjaro affect your periods covers the first and pregnancy and Mounjaro the second. A GP or sexual health clinic can switch you to a non-oral method, ideally before the first dose.

Does Mounjaro affect HRT?

If your HRT is a tablet, possibly; nobody has tested it. Oral oestrogen and progestogen are absorbed through the gut like the pill, and the product information carries no instruction because the trials did not study it. A 2026 review searched the literature to February 2026 and found no study of tirzepatide with the progestogens used in HRT, calling the interaction biologically plausible but unproven, and noting that the pill study's smaller fall in total exposure shows a lower peak is not the same as lower effectiveness.5 One published case describes a 51-year-old on oral oestrogen whose hot flushes and mood worsened during dose increases of a related GLP-1 medicine and settled when the increases were slowed.4 Thin evidence, fairly described: enough to watch for, not enough to say it will happen.

Practically: if menopause symptoms you had under control return in the weeks after starting tirzepatide or moving up a dose, tell whoever prescribes your HRT and mention the tirzepatide. Patches, gel and spray deliver oestrogen through the skin and are unaffected by the stomach; the NHS notes that blood clot risk is also lower with them than with tablets.7 Do not change your HRT dose yourself, and do not stop tirzepatide to find out; both are prescriber decisions.

Emergency contraception and vaginal oestrogen

The emergency contraceptive pill is swallowed and absorbed through the gut, so if you need it while on tirzepatide, say so at the pharmacy or clinic. The NHS says the copper coil is the most effective type of emergency contraception, can be fitted within five days of sex, and does not depend on absorption; the two pills must be taken within three or five days respectively.10 Vaginal oestrogen, used for dryness and urinary symptoms, acts where it is placed and is not swallowed, so the stomach does not come into it; vaginal dryness at any age covers the options.7

Does Mounjaro affect your hormones?

Not as a hormone treatment. Tirzepatide acts on the GIP and GLP-1 receptors, and the product information lists no effect on oestrogen or the ovaries.1 What changes hormones is the weight loss: a 2026 review notes that GLP-1 medicines may improve menstrual regularity in polycystic ovary syndrome through better insulin resistance and androgen profiles.9 So periods can change and fertility can return, which is the contraception point above.

Mounjaro at the menopause

The NHS defines the menopause as twelve months without a period, with hot flushes, poor sleep, mood changes and weight gain around the middle among its symptoms.11 Tirzepatide changes the weight; four practical points follow.

Muscle and bone. The NHS advice at the menopause is weight-bearing and resistance exercise, calcium-rich food and vitamin D, and fast weight loss adds to the case: about a quarter of the weight lost in the tirzepatide body-composition study was lean tissue.12, 13 Protein at 1.2 to 1.6 g per kilogram a day and resistance exercise two or three times a week; does Mounjaro cause muscle loss explains why, and creatine in perimenopause and menopause covers what the postmenopausal trials measured. Vitamin D at 10 micrograms a day from October to March is NHS advice for every adult and contributes to the maintenance of normal bones.14

Hot flushes. Flushes returning on oral HRT after a dose change are the absorption question above; tell your prescriber rather than guessing.

Iron. Heavy periods are the first cause of iron deficiency the NHS names, so after the menopause it is less common; if you are tired or cold, a blood test comes first, so that any iron you take corrects a measured shortfall.15

Bleeding. The NHS says to see a GP about any bleeding from the vagina after the menopause, even if it is small or has happened only once, whatever you are taking.16

What we don't know

  • Whether tirzepatide changes oral HRT absorption; the evidence is pharmacological reasoning and one case report from a related medicine.4, 5
  • The size of the pill effect after repeated doses; the study was a single dose, and the delay diminishes with time.1, 6
  • Effects on the menopause transition itself; not studied in the trials.

Frequently asked questions

Does Mounjaro make the pill less effective?

It may, in the four weeks after starting and after each dose increase: a single dose cut the pill's peak hormone levels by 55% to 66%. The product information, the NHS and the MHRA advise a barrier or non-oral method in those windows.1, 2, 3

Can I take HRT with Mounjaro?

Yes. Tablets may be absorbed differently in the slow-stomach windows; patches, gel and spray are unaffected. If symptoms return, tell your HRT prescriber.4, 5, 7

Does Mounjaro affect menopause symptoms?

Not hormonally; it has no listed effect on oestrogen.1 Women on oral HRT occasionally report flushes returning after a dose change. Protein, resistance exercise and bone deserve extra attention.12, 13

Is the coil or implant affected by Mounjaro?

No. Implants, coils, injections, patches and rings do not go through the stomach.1

Sources

  1. Tirzepatide Summary of Product Characteristics, sections 4.5 (gastric emptying; oral contraceptive study and the 4-week advice), 4.6 (pregnancy) and 5.1 (mechanism; delay in gastric emptying diminishes over time), electronic medicines compendium, date of revision of the text 29 August 2026. medicines.org.uk.
  2. NHS. Tirzepatide. Page last reviewed 15 May 2026. nhs.uk.
  3. MHRA. Women on "skinny jabs" must use effective contraception. Press release, 5 June 2025; and GLP-1 medicines: what you need to know, updated 5 February 2026. gov.uk.
  4. Parker AE. Worsening vasomotor symptoms in the setting of estradiol and semaglutide: a case report. Menopause, 2025. Single case report; no conflicts reported. PubMed 40729307.
  5. Viana DPDC, et al. Tirzepatide and oral progestogens: a hypothesis-generating review of a biologically plausible pharmacokinetic interaction. Maturitas, 2026. Narrative review, literature to February 2026; funding not stated on PubMed. PubMed 42721915.
  6. Urva S, et al. Tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists. Diabetes, Obesity and Metabolism, 2020. Phase 1 randomised study, 4 weeks; manufacturer employees among the authors. PubMed 32519795.
  7. NHS. Types of hormone replacement therapy (HRT). Page last reviewed 9 March 2023 (review overdue). nhs.uk.
  8. Min JS, et al. A comprehensive review on the pharmacokinetics and drug-drug interactions of approved GLP-1 receptor agonists and a dual GLP-1/GIP receptor agonist. Drug Design, Development and Therapy, 2025. Narrative review; funding not stated on PubMed. PubMed 40330819.
  9. Porterfield F, et al. GLP-1 receptor agonists and reproductive health: implications for contraception, fertility, and pregnancy. Endocrinology and Metabolism Clinics of North America, 2026. Narrative review; senior author declares consulting fees from manufacturers. PubMed 42907053.
  10. NHS. Emergency contraception. Page last reviewed 31 January 2024. nhs.uk.
  11. NHS. Menopause: symptoms. Page last reviewed 19 May 2026. nhs.uk.
  12. NHS. Menopause: things you can do. Page last reviewed 19 May 2026. nhs.uk.
  13. Look M, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study. Diabetes, Obesity and Metabolism, 2025. Scan substudy of a randomised trial, 160 adults, 72 weeks; manufacturer-funded. PubMed 39996356.
  14. NHS. Vitamin D. Page last reviewed 3 August 2020 (review overdue). nhs.uk.
  15. NHS. Iron deficiency anaemia. Page last reviewed 26 January 2024. nhs.uk.
  16. NHS. Post-menopausal bleeding. Page last reviewed 24 September 2026. nhs.uk.

Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.

General information, not personal medical advice. Mounjaro is a prescription medicine: follow the product information and your prescriber's advice on contraception and HRT, and never change either dose yourself.